Equity in drug pricing could enhance access across countries with varying economic conditions.
Key strategies include pooled procurement and tiered pricing to mitigate costs for disadvantaged populations.
Policy recommendations target national policies that contribute to drug pricing inequities.
Collaborative international efforts could shift the landscape of access to essential medications.
Abstract
Zoltán Kaló and colleagues consider approaches to counter systemic inequities and power imbalances arising from discrete national policies for drug pricing and reimbursement